Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION™ platforms.
| Registrars: |
Capita Registrars |
| CEO: |
Christina Coughlin |
| CFO: |
Tony Peter Gardiner |
| Non-Executive Director: |
Paul Fry, Mark Goldberg, Trevor Nichols |
| Non-Executive Chairman: |
Shaun Chilton |
| Address: |
Unit 20, Ash Way, Thorp Arch Estate, Wetherby, United Kingdom |
| Phone: |
+44 (0)1904 21 7070 |
| Fax: |
+44 (0)84 4414 0453 |
| Website: |
http://www.avacta.com |
| Email: |
|